title: H1N1 influenza in pregnancy: risks, vaccines, and antivirals.
abstract: When pregnant women are infected by the H1N1 influenza A virus, the consequences are more serious than they are in other groups of patients. It is imperative to vaccinate pregnant women against this virus. Unvaccinated women who come in contact with the virus should receive prophylactic antiviral therapy. The existing information on the safety of oseltamavir and zanamavir, the most used antivirals, is limited but reassuring.
authors.affiliation: Motherisk Program, Hospital for Sick Children, Toronto ON, Canada.
authors.forename: Pina
authors.initials: P
authors.lastname: Bozzo
authors.forename: Nada
authors.initials: N
authors.lastname: Djokanovic
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control; D053139:Oseltamivir / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000517:prevention & control; D012307:Risk Factors; D053243:Zanamivir / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D053243:Zanamivir